A Computationally Optimized Ribonucleic Acid Circularization Strategy without Byproducts
Journal of the American Chemical Society · 10.09.2025 · 147 (36) · 32932-32940
DOI: 10.1021/jacs.5c09798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 28.08.2025. Verfasst von Ruofan Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Advanced Rare Earth Materials (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, C…. Hauptthemen laut MEDLINE: RNA, Circular, RNA, Messenger, RNA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Circular mRNA (mRNA) exhibits promising potential in mRNA therapy due to its increased stability and extended duration of protein translation, which has sparked an urgent demand for efficient methods to prepare circular RNAs in vitro. Here, we present a versatile self-circularization strategy that employs simple motifs to synthesize circular RNAs, achieving robust efficiencies for sequences ranging from dozens to thousands of nucleotides. By leveraging an automated computational program, we optimized highly specific lock-key structures to maximize circularization efficiency, particularly for long RNA substrates. Furthermore, the shared sequence and functionality between linear precursor RNAs and circular products eliminate the need for additional purification steps to remove excess nucleic acid components, simplifying the production process. This approach also yields circular RNAs with superior stability and translation efficiency, enabling sustained protein expression in vitro and in vivo. Our computationally optimized, purification-free method holds immense promise for scalable circular RNA production and the development of advanced RNA therapeutics, significantly advancing mRNA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Advanced Rare Earth Materials (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, China.
- Innovative Drug Research Center, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Beijing Supracirc Biotechnology CO. LTD, 201, Floor 2, Building 2, Yiyuan District B, No. 80 Xingshikou Road, Haidian, Beijing 100195, China.
- School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
- Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310018, China.
- CAS Key Laboratory of Colloid Interface and Chemical Thermodynamics, Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
ORCID-Profile: Ruofan Chen, Yuanchen Dong, Dongsheng Liu
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
- Beijing Municipal Science and Technology Commission
Zitieren
APA
Chen, R., Zhuang, Y., Zhang, L., Wu, Y., Luo, L., Pan, Y., Li, Y., Zhu, C., Xu, R., Jiang, Y., Hao, Z., Tian, B., Zhang, L., Dong, Y., & Liu, D. (2025). A Computationally Optimized Ribonucleic Acid Circularization Strategy without Byproducts. Journal of the American Chemical Society, 147(36), 32932-32940. https://doi.org/10.1021/jacs.5c09798
Vancouver
Chen R, Zhuang Y, Zhang L, Wu Y, Luo L, Pan Y, et al. A Computationally Optimized Ribonucleic Acid Circularization Strategy without Byproducts. Journal of the American Chemical Society. 2025;147(36):32932-32940. doi:10.1021/jacs.5c09798
BibTeX
@article{Chen2025,
author = {Chen, Ruofan and Zhuang, Yuan and Zhang, Li and Wu, Yuanyuan and Luo, Liangzhi and Pan, Yufan and Li, Yujie and Zhu, Chenyou and Xu, Rui and Jiang, Yifan and Hao, Ziyang and Tian, Baolei and Zhang, Liang and Dong, Yuanchen and Liu, Dongsheng},
title = {A Computationally Optimized Ribonucleic Acid Circularization Strategy without Byproducts},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {36},
pages = {32932--32940},
doi = {10.1021/jacs.5c09798}
}
EUVIMED